Emerging Leaders Lectures – Selection & Recipients
The purpose of the JGHF Emerging Leader Lectures is to recognise young scientists and clinical scientists within the region and encourage them as the ‘rising stars’ of the future.
From 2026 Allied Health and Nursing Emerging Leader will be added to the Emerging Leader Award category
Optimal patient outcomes reply on the coordinated expertise and efforts of a multidisciplinary team. The purpose of the Emerging Leader in Allied Health and Nursing Lecture is to recognise and encourage outstanding young allied health and nursing practitioners and researchers within the Asia-Pacific region.
This award aims to celebrate excellence, foster leadership, and highlight individuals who are shaping the future of GE healthcare through innovation, scholarship, and service. There is currently a low level of formal recognition for the role these professionals play as part of the multidisciplinary teams at APDW (or across the AP Region).
The Allied Health and Nursing category will align with this aim, acknowledging the critical role allied health and nursing professionals play in multidisciplinary patient care, research innovation, and leadership. It signals formal recognition by JGHF (and by association the Journals), the integral role these professionals play in delivering optimum GE health and care to patients.
The award will form part of the JGHF Emerging Leader Lectures awards delivered at APDW and will extend eligibility to professionals across allied health and nursing disciplines, including (but not limited to):
- Nursing (all gastrointestinal related fields e.g. Hepatology, IBD, stoma, enteric, endoscopy, nurses)
- Dietetics and Nutrition
- Endoscopy Technicians
- Psychology
- Pharmacy
- Speech Pathology
- Physiotherapy
- other related disciplines.
Terms and Conditions for the EL Lecture Award are below.
selection
- Nominees must be forty-five (45) years of age or younger at the time the nomination is submitted.
- Provide their CV and title of their lecture and abstract.
- Demonstrate excellence in research, and that they are an outstanding contributor in their age group.
- In principal be established in their own right i.e. be a senior practitioner for their career level.
- Must submit a review article for publication in the journal.
- Provide their submission via their local society demonstrating how they meet the selection criteria.
- Be received by 31 July each year.
Conditions
- Maximum of one (1) medical/scientist and 1 (one) Allied Health/Nursing nominee per country.
- A total of three (3) lectures per meeting are awarded.
- The Trustees of the JGHFoundation will make the final decision on the selection of the three (3) lecturers.
Funding
- Return economy class airfare (premium economy if more than 4 hours) between home city and the venue for APDW.
- Accommodation in a single room at one of the conference hotels to cover the night before speaking engagement and the night of the engagement (max 2 nights)
- Honorarium of AUD3.8k when manuscript is selected for publication in JGH. Payments if made by the JGHFoundation upon receipt of a Reimbursement Form with evidence of submission acceptance.
Manuscript
- Each lecturer is required to submit a manuscript for publication in the Journal of Gastroenterology and Hepatology (JGH) that covers the content of their lecture.
- The manuscript should be structured as a review article between 2,500-3,000 words. For information on JGH style guidelines please see the Wiley House Style Guide.
Past award recipients
| Year | Recipient | City | Topic |
|---|---|---|---|
| 2025 | Julajak Limsrivilai | Bangkok | Differentiating Crohn’s Disease from Intestinal Tuberculosis: Current Challenges and Future Directions |
| Mark Muthiah | Singapore | Applying novel insights to overcome management challenges in the patients with MASH cirrhosis | |
| 2024 | Beom Kyung Kim | Seoul | Future Perspectives of Liver Research in the Asia Pacific region |
| Tsuyoshi Hamada | Tokyo | Intraductal Papillary Mucinous Neoplasm: A Multifaceted Approach to Understanding and Managing Pancreatic Precursor Lesions | |
| 2023 | Tiffany Wong | Hong Kong | Extending the limit for liver transplantation – Challenging the status quo |
| Ka-Shing Cheung | Hong Kong | Big data approach in the field of gastric cancer and colorectal cancer research | |
| 2022 | Yoichi Kakuta | Sendai | IBD Genetics in East Asia –From population to an individual |
| Surinder Singh Rana | Chandigarh | Endoscopic Treatment of Pancreatic Necrosis: Still Searching For Perfection | |
| 2021 | Sunny Wong Hei | Hong Kong | Gut Microbiota in Digestive Cancers: Are We Ready for Clinical Application? |
| Goki Suda | Sapporo | Recent Advance in the Treatment of Hepatitis C Virus Infection for Special Populations | |
| 2019 | Jyh-Ming Liou | Taipei | Short-term and long-term impacts of H. pylori eradication on the gut microbiota and metabolic parameters |
| Anthony Teoh | Hong Kong | Endosonography-guided anastomosis and interventions | |
| 2018 | Yoshimasa Saito | Tokyo | Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy |
| Wai-Kay Walter Seto | Hong Kong | Disease outcomes of chronic hepatitis B in the era of nucleoside analogue therapy | |
| 2017 | Grace Wong | Hong Kong | Non-invasive assessments for liver fibrosis – the crystal ball we long for |
| Norihisa Ishimura | Shimane | Eosinophilic esophagitis and proton pump inhibitor-responsive eosinophilia: distinct disease entities? | |
| 2016 | Philip Chiu | Hong Kong | Innovation and Advances in Endoscopic Surgery |
| Ming-Lung Yu | Kaohsiung | Treatment of chronic HCV infection: From Response-guided therapy to Resource-guided therapy in the transition era from Interferon-containing to Interferon-free regimens | |
| 2015 | Chun-Ying Wu | Taichung | A Roadmap to Prevent Digestive Cancers: From molecular studies, clinical researches, big data analyses, to personal risk prediction and biochips development |
| Young-Suk Lim | Seoul | Achieving the Goal of Hepatitis B Treatment | |
| 2014 | Siew Chien Ng | Hong Kong | Inflammatory bowel disease in Asia: emergence of a “Western Disease” |
| Yock Young Dan | Singapore | Liver’s Holy Grail? – The Somatic Liver Stem Cell and its Therapeutic Applications | |
| 2013 | Katsunori Iijima | Sendai | Involvement of luminal nitric oxide in the pathogenesis of gastro-esophageal reflux disease spectrum |
| Chun-Jen Liu | Taipei | Dual HCV and HBV Infection: Resolved and unresolved issues | |
| 2012 | Vincent Wai Sung, Wong | Hong Kong | Nonalcoholic Fatty Liver Disease in Asia – A Story of Growth |
| Jae Hee Cheon | Seoul | Genetics and epigenetics in the pathogenesis of inflammatory bowel diseases | |
| 2011 | Manoj Sharma | New Delhi | Chronic hepatitis B infection and normal ALT: treat or not to treat? |
| Ping-I Hsu | Kaohsiung | A new look at antiplatelet agent-related peptic ulcer: An update of prevention and treatment | |
| 2010 | Henry Lik-Yuen Chan | Hong Kong | The decoding of HBV genomics by a clinician |
| Khek-Yu Ho | Singapore | From GERD to Barrett’s oesophagus: Is the pattern in Asia mirroring that in the West? | |
| 2009 | Bor-Shyang Sheu | Taipei | Helicobacter Pylori Colonization of the Human Gastric Epithelium: the First Step of Bug & Novel Target for Us. |
| Rong-Nan Chien | Taipei | On Treatment Monitoring of Chronic Hepatitis B Virus Infection: an Asian Pacific Perspective | |
| 2008 | Ming-Shiang Wu | Taipei | Proteomic identifications of biomarkers related to Helicobacter pylori-associated gastroduodenal diseases: challenges and opportunity |
| Che-Yuen Justin Wu | Hong Kong | Gastroesophageal reflux disease:An Asian perspective | |
| 2007 | Kai-Chun Wu | Xian | Molecular basis of therapeutic approaches to gastric cancer |
| Isao Sakaida | Japan | Autologous bone marrow cell infusion ( ABMI ) therapy for liver cirrhosis |